Table 3.
Perioperative metrics following anterior thoracic vertebral body tethering and posterior lumbar spine tethering
| TAVBT/PLST (N = 14) | |
|---|---|
| Tethered levels | |
| Total | 11.9 ± 0.5 |
| Anterior thoracic | 7.6 ± 0.8 |
| Posterior lumbar | 5.1 ± 0.7 |
| Upper instrumented vertebrae (UIV) | |
| Anterior: T4 UIV | 4 (28%) |
| Anterior: T5 UIV | 8 (57%) |
| Anterior: T6 UIV | 2 (14%) |
| Posterior: T10 UIV | 1 (7%) |
| Posterior: T11 UIV | 4 (28%) |
| Posterior: T12 UIV | 8 (57%) |
| Posterior: L1 UIV | 1 (7%) |
| Lowest instrumented vertebrae (LIV) | |
| Anterior: T10 LIV | 1 (7%) |
| Anterior: T11 LIV | 5 (35%) |
| Anterior: T12 LIV | 8 (57%) |
| Posterior: L3 LIV | 4 (28%) |
| Posterior: L4 LIV | 10 (72%) |
| Intraoperative Complications | 0% |
| ASA Classification | |
| 1 | 8 (57%) |
| 2 | 6 (43%) |
| Overall Length of Stay (days) | |
| Overall Length of Stay (days) | 4.1 ± 0.6 |
| Case length (min) | 418.9 ± 111.3 |
| Estimated Blood Loss (mL) | 173.3 ± 81.2 |
| Foley duration (h) | 57 ± 17 |
| Days to solid food | 1.1 ± 0.8 |
| 30-day readmission | 0% |
| Opioid Morphine Equivalent | |
| OME Intraop (mg/kg) | 7.2 ± 3.1 |
| OME POD 0 (mg/kg) | 0.4 ± 0.7 |
| OME POD 1 (mg/kg) | 1.0 ± 1.4 |
| OME POD 2 (mg/kg) | 1.2 ± 1.0 |
| OME POD 3 (mg/kg) | 1.0 ± 0.5 |
| Total post-operative OME (mg/kg) | 4.3 ± 3.2 |
| Post-operative Epidural Infusion | 2/14 (14%) |
| Post-operative Gabapentin | 9/14 (64%) |
Means with standard deviations are provided
Significant values are defined as p < 0.05